Document is current
Any future updates will be listed below
-
Authors
Rouhani, Foad J. https://orcid.org/0000-0002-2334-1305
Zou, Xueqing https://orcid.org/0000-0003-1143-1028
Danecek, Petr
Badja, Cherif https://orcid.org/0000-0003-3736-672X
Amarante, Tauanne Dias
Koh, Gene
Wu, Qianxin
Memari, Yasin
Durbin, Richard
Martincorena, Inigo https://orcid.org/0000-0003-1122-4416
Bassett, Andrew R. https://orcid.org/0000-0003-1632-9137
Gaffney, Daniel https://orcid.org/0000-0002-1529-1862
Nik-Zainal, Serena https://orcid.org/0000-0001-5054-1727
-
Funding
Funding for this research was provided by:
Cancer Research UK (C60100/A23916)
Wellcome Trust (WT100183)
DH | National Institute for Health Research (MR/R015724/1)
Dr Josef Steiner Cancer Research Award 2019, Medical Research Council (MRC) Grant-in-Aid to the MRC Cancer unit, CRUK Pioneer Award
- License Information
-
More Information
Article History
Received: 6 May 2021
Accepted: 24 June 2022
First Online: 11 August 2022
Competing interests
: S.N.-Z. holds patents on mutational signature based clinical algorithms although these are not relevant to the research in this paper. The remaining authors declare no competing interests.
